Ma T, Jiao J, Huo R, Li X, Fang G, Zhao Q, et al. PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations. Front Oncol. 2022;12:922899.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garrido F, Aptsiauri N. Cancer immune escape: MHC expression in primary tumours versus metastases. Immunology. 2019;158:255–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naqash AR, McCallen JD, Mi E, Iivanainen S, Marie MA, Gramenitskaya D et al. Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer 2023;11.

Davis AA, Patel VG. The role of PD-L1 expression as a predictive biomarker: an analysis of all US food and drug administration (FDA) approvals of immune checkpoint inhibitors. J Immunother Cancer. 2019;7:278.

Article  PubMed  PubMed Central  Google Scholar 

Abu Hejleh T, Furqan M, Ballas Z, Clamon G. The clinical significance of soluble PD-1 and PD-L1 in lung cancer. Crit Rev Oncol Hematol. 2019;143:148–52.

Article  PubMed  Google Scholar 

Marzbani E, Inatsuka C, Lu H, Disis ML. The invisible arm of immunity in common cancer chemoprevention agents. Cancer Prev Res (Phila). 2013;6:764–73.

Article  CAS  PubMed  Google Scholar 

Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP, et al. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet. 2020;395:1855–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Florensa D, Mateo J, Solsona F, Galvan L, Mesas M, Pinol R, et al. Low-dose acetylsalicylic acid for cancer prevention considering risk factors: a retrospective cohort study. Ann Epidemiol. 2023;84:60–6.

Article  PubMed  Google Scholar 

Neville-Webbe HL, Coleman RE, Holen I. Combined effects of the bisphosphonate, Zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer. 2010;102:1010–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun M, Yu J, Wan J, Dou X, Chen X, Ye F. Role of aspirin in cancer prevention. Cancer Treat Res Commun. 2025;43:100884.

PubMed  Google Scholar 

Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M, et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun. 2002;291:884–9.

Article  CAS  PubMed  Google Scholar 

Michaud A, Lacroix-Pepin N, Pelletier M, Daris M, Biertho L, Fortier MA et al. Expression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis. Mediators Inflamm. 2014;2014:451620.

Liu Y, Fang S, Li X, Feng J, Du J, Guo L, et al. Aspirin inhibits LPS-induced macrophage activation via the NF-kappaB pathway. Sci Rep. 2017;7:11549.

Article  PubMed  PubMed Central  Google Scholar 

Xiao M, He J, Yin L, Chen X, Zu X, Shen Y. Tumor-Associated macrophages: critical players in drug resistance of breast cancer. Front Immunol. 2021;12:799428.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Q, Guo N, Zhou Y, Chen J, Wei Q, Han M. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B. 2020;10:2156–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kowal J, Kornete M, Joyce JA. Re-education of macrophages as a therapeutic strategy in cancer. Immunotherapy. 2019;11:677–89.

Article  CAS  PubMed  Google Scholar 

Chamseddine AN, Assi T, Mir O, Chouaib S. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach. Pharmacol Ther. 2022;231:107986.

Article  CAS  PubMed  Google Scholar 

Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE. 2015;10:e0145342.

Article  PubMed  PubMed Central  Google Scholar 

Amici SA, Young NA, Narvaez-Miranda J, Jablonski KA, Arcos J, Rosas L, et al. CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions. Front Immunol. 2018;9:1593.

Article  PubMed  PubMed Central  Google Scholar 

Yao Y, Xu XH, Jin L. Macrophage polarization in physiological and pathological pregnancy. Front Immunol. 2019;10:792.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gunalp S, Helvaci DG, Oner A, Bursali A, Conforte A, Guner H, et al. TRAIL promotes the polarization of human macrophages toward a Proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. Front Immunol. 2023;14:1209249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madeddu C, Donisi C, Liscia N, Lai E, Scartozzi M, Maccio A. EGFR-mutated non-small cell lung cancer and resistance to immunotherapy: role of the tumor microenvironment. Int J Mol Sci 2022;23.

Chung FT, Lee KY, Wang CW, Heh CC, Chan YF, Chen HW, et al. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer. Int J Cancer. 2012;131:E227–35.

Article  CAS  PubMed  Google Scholar 

Hamada T, Giannakis M, Ogino S. Aspirin in the era of immunotherapy. Oncotarget. 2017;8:73370–1.

Article  PubMed  PubMed Central  Google Scholar 

Smith WL. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem Sci. 2008;33:27–37.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Lv C, Dong Y, Yang Q. Aspirin-targeted PD-L1 in lung cancer growth Inhibition. Thorac Cancer. 2020;11:1587–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sezginer O, Unver N. Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization. Inflamm Res. 2024;73:1411–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Li Y, Jin X, Liao Q, Chen Z, Peng H, et al. CD38: A significant regulator of macrophage function. Front Oncol. 2022;12:775649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015;2015:816460.

Article  PubMed  PubMed Central  Google Scholar 

Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2019;106:345–58.

Article  CAS  PubMed